红外吸收光谱、核磁共振谱和质谱确证比卡鲁胺的结构

Structural Determination of Bicalutamide by IR,NMR and MS

下载PDF

导出

摘要测试样品和国外比卡鲁胺对照品的红外吸收光谱、核磁共振谱、质谱。对比结果表明。 The structure of bicalutamide was confirmed by IR,NMR and MS.

作者巴琳赵晓峰孟祥军刘雅茹

机构地区沈阳医学院化学教研室同联集团沈阳抗生素厂

出处《光谱实验室》 CAS CSCD 2004年第5期950-954,共5页 Chinese Journal of Spectroscopy Laboratory

关键词比卡鲁胺红外吸收光谱核磁共振谱质谱 Bicalutamide,IR,NMR,MS.

参考文献2

1[1]Dole EJ,Holdsworth MT,Nilutamide:Antiandrogen for the treatment of prostate cancer[J].Ann Pharmacother,1997,31(1)∶65-74. 被引量：1
2[2]Tucker H.Non-steroidal anti-androgens in the treatment of prostate cancer[J].Drugs Fut,1990,15(3)∶255-265. 被引量：1
3[3]Bicalutamide.Drugs Future,1997,22(3)∶298-299. 被引量：1
4[4]Lunglmayr G,the International Casodex Study Group.Efficacy and toterability of Casodex in patients with advanced prostate cancer[J].Anti-cancer Drugs,1995,6(4)∶508-513. 被引量：1
5[5]Bicalutamide.Drugs Future,1996,21(3)∶305-307. 被引量：1
6[6]Juniewic PE,Hoekstra SJ.Effects of combination treatment with zanoterone(win 49596),a steroidal androgen receptor antagonist,and finasteride(MK-906),a steroidal 5a-reductase inhibtor,on the prostate and testes of beagle dogs[J].Endocrinology,1993,133(2)∶905-913. 被引量：1
7[7]Osaterone Acetate.Drugs Future,1993,18(6)∶516-519. 被引量：1
8[8]Osaterone Acetate.Drugs Future,1995,20(6)∶633-635. 被引量：1
9[9]Osaterone Acetate.Drugs Future,1998,23(6)∶682-683. 被引量：1
10[10]Sharifi R,Ratanawong C,Jung A,et al.Therapeutic effects of leuprorelin microspheres in prostate cancer[J].Adv Drug Delivery Rev,1997,28(1)∶121-138. 被引量：1

光谱实验室

2004年第5期

内容加载中请稍等...